Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13145525 | 0.78 | CA2 (0.40) | CA2ALDH1A1TSHRTDP1 | |
| SCHEMBL8737183 | 0.65 | — | — | |
| SCHEMBL11674582 | 0.64 | CA2 (0.43) | CA2ALDH1A1TSHRTDP1ALOX15 | |
| SCHEMBL12611143 | 0.63 | MAPT (0.35) | CA2ALDH1A1TSHRTDP1ALOX15 | |
| SCHEMBL812457 | 0.63 | NOS3 (0.36) | TSHRCYP1A2MAPT | |
| SCHEMBL20087061 | 0.62 | — | — | |
| SCHEMBL17154859 | 0.62 | TSHR (0.35) | CA2ALDH1A1TSHRTDP1KDM4E | |
| SCHEMBL20087066 | 0.62 | — | — | |
| SCHEMBL11955219 | 0.62 | SSTR4 (0.41) | CA2ALDH1A1TSHRTDP1KDM4E | |
| SCHEMBL7136409 | 0.61 | CA2 (0.41) | CA2ALDH1A1TSHRTDP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180026200-A1 | HETEROCYCLIC COMPOUND AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180026200-A1 | HETEROCYCLIC COMPOUND AND ORGANIC SOLAR CELL COMPRISING SAME | SUN2, CRY1, STOM | CA2 528/4885ALDH1A1 1159/4885TSHR 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.